IndieBio helps entrepreneurs build ground-breaking biotech companies. We’re excited to share our ninth class of 11 new startups. They have been here for thirty days, working tirelessly to derisk [...]

Beeline takes engineered immune cell therapy in a new direction. They are unique in how they have engineered regulatory T cells (Tregs), which play a natural role in ramping down the immune [...]

Gavilán Biodesign emerged out of the Donald Lab at Duke University, one of the world leaders in computational drug design. During their time at Duke, they redesigned many compounds, including a [...]

The CRISPR Cas complex has been a game-changing technology for gene editing. CASPR Biotech is using the incredible accuracy of CRISPR for something different — to revolutionize medical [...]

At IndieBio, our perspective on gut bacteria is informed not just by the companies we’ve invested in that do human microbiome science, but by all the companies in our portfolio who work with [...]

We’re excited to announce our eighth class at IndieBio. IndieBio invests in revolutionary technologies for human and planetary health, and each of these companies, though small today, has [...]

Arvind Gupta, Managing Director & Founder of IndieBio: Meeting the challenge of climate change is commonly characterized as a tradeoff with industrial economic growth. In order to save the [...]

Guest post By Bryan Johnson, founder of Kernel, OS Fund, and Braintree Saving the world (or some subset of people in it) is in vogue among the world’s wealthiest. Jeff Bezos has a rocket company, [...]

Americans spend over 40 billion dollars every year taking care of their oral health, yet conditions like bad breath, gum disease, and tooth decay are incredibly common. Oralta is looking to [...]

Chronus Health’s portable device allows for real-time diagnosis at the point-of-care providing lab results in minutes, dramatically improving time to care and patient outcomes. Our initial launch [...]